Redx Pharma is a drug discovery and development company formed in 2010. It is focused on improving the characteristics of existing drug classes to create new drugs in the areas of cancer, immunology and infection. The company's work has been endorsed by partnerships with global pharmaceutical companies and the NHS.

Find out more


Latest News

In Administration
24 May 2017

The affairs, business and property of the Redx Pharma Plc and Redx Oncology Limited are being managed by Jason Baker and Miles Needham who were appointed Joint Administrators on 24 May 2017. The Joint Administrators act as agents of the Companies and without personal liability.

Read more

In The Media

17 May 2017
Redx Pharma “in a very good place with great assets”

ProactiveInvestors.co.uk

31 Mar 2017
US$1mln grant is ‘testament to the great science’ ongoing at Redx, CSO says

ProactiveInvestors.co.uk

21 Mar 2017
Redx Pharma to refocus on key assets

ProactiveInvestors.co.uk